Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             50 results found
no title author magazine year volume issue page(s) type
1 ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells Davis, Brian M.

104 2 p. 364-373
article
2 Activating FLT3 mutations in CD117/KIT+ T-cell acute lymphoblastic leukemias Paietta, Elisabeth

104 2 p. 558-560
article
3 A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome Cutler, Corey S.

104 2 p. 579-585
article
4 Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome Gulino, Anna Virginia

104 2 p. 444-452
article
5 A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome–positive acute lymphoblastic leukemia Soda, Yasushi

104 2 p. 356-363
article
6 Anticoagulation by a thrombin precursor Krishnaswamy, Sriram

104 2 p. 301
article
7 A “Ras-in-ALL” model of signaling? Loh, Mignon

104 2 p. 297-298
article
8 A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury Shim, Kyuhwan

104 2 p. 415-419
article
9 A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories Herling, Marco

104 2 p. 328-335
article
10 Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice Bagley, Jessamyn

104 2 p. 572-578
article
11 Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms Dai, Yun

104 2 p. 509-518
article
12 CB2, a paradigm for a novel class of “onco-GPCRs”? Casellas, Pierre

104 2 p. 302-303
article
13 Childhood stroke frequency decreased in California during 1999 and 2000 Powars, Darleen R.

104 2 p. 298-299
article
14 Clotting and cancer progression: platelets count Bromberg, Michael E.

104 2 p. 300
article
15 Complete remission of TEL-PDGFRB–induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657 Cain, Jennifer A.

104 2 p. 561-564
article
16 Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma Guiter, Chrystelle

104 2 p. 543-549
article
17 CXCR-4: homing in on Flt3 Levis, Mark

104 2 p. 303-304
article
18 Declining stroke rates in Californian children with sickle cell disease Fullerton, Heather J.

104 2 p. 336-339
article
19 De novo T-cell generation in patients at different ages and stages of HIV-1 disease Nobile, Massimo

104 2 p. 470-477
article
20 Direct evidence of leukocyte adhesion in arterioles by angiotensin II Álvarez, Ángeles

104 2 p. 402-408
article
21 Donor-derived TNF-α regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Hildebrandt, Gerhard C.

104 2 p. 586-593
article
22 Dotting the I of an I-domain Bennett, Joel S.

104 2 p. 299-300
article
23 Editorial Board
104 2 p. i
article
24 Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production Gilchrist, Mark

104 2 p. 462-469
article
25 Genetic evidence for lineage-related and differentiation stage–related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia Tartaglia, Marco

104 2 p. 307-313
article
26 Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial Casadevall, Nicole

104 2 p. 321-327
article
27 Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains Takahashi, Toru

104 2 p. 594
article
28 HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor–α Lichterfeld, Mathias

104 2 p. 487-494
article
29 Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas Trentin, Livio

104 2 p. 502-508
article
30 Identification of a novel 14-3-3ζ binding site within the cytoplasmic tail of platelet glycoprotein Ibα Mangin, Pierre

104 2 p. 420-427
article
31 Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia Legros, Laurence

104 2 p. 495-501
article
32 Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect Gismondi, Angela

104 2 p. 436-443
article
33 Individualized risks of first adverse events in patients with Fanconi anemia Rosenberg, Philip S.

104 2 p. 350-355
article
34 Interleukin-1β but not IL-1α binds to fibrinogen and fibrin and has enhanced activity in the bound form Sahni, Abha

104 2 p. 409-414
article
35 In vitro–expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell–stimulated MLR cultures Godfrey, Wayne R.

104 2 p. 453-461
article
36 LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22) Coleman Jr, Leon G.

104 2 p. 380-389
article
37 Monoclonal antibody IAC-1 is specific for activated α2β1 and binds to amino acids 199 to 201 of the integrin α2 I-domain Schoolmeester, Anne

104 2 p. 390-396
article
38 Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions Nascimbeni, Michelina

104 2 p. 478-486
article
39 Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Camerer, Eric

104 2 p. 397-401
article
40 Positive and negative regulatory roles of the WW-like domain in TEL-PDGFβR transformation Chen, Jing

104 2 p. 535-542
article
41 Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation Kaiser, Thorsten

104 2 p. 340-349
article
42 Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice Henckaerts, Els

104 2 p. 374-379
article
43 Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments Øynebråten, Inger

104 2 p. 314-320
article
44 Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia Rombouts, ElwinJ.C.

104 2 p. 550-557
article
45 Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis Suratt, Benjamin T.

104 2 p. 565-571
article
46 The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner Alberich Jordà, Meritxell

104 2 p. 526-534
article
47 The prothrombin 3′end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations Danckwardt, Sven

104 2 p. 428-435
article
48 The WHIMs of leukocytes Holland, Steven M.

104 2 p. 301-302
article
49 Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells Lunghi, Paolo

104 2 p. 519-525
article
50 When to transplant in myelodysplasia? Markov helps Szer, Jeff

104 2 p. 304-305
article
                             50 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands